2002
DOI: 10.1038/sj.ejhg.5200793
|View full text |Cite
|
Sign up to set email alerts
|

Succinate dehydrogenase and human diseases: new insights into a well-known enzyme

Abstract: Inherited defects of the mitochondrial succinate dehydrogenase (SDH) in humans are associated with striking variable clinical presentations ranging from early-onset devastating encephalomyopathy to tumour susceptibility in adulthood, or optic atrophy in the elderly. Although different genes encoding the four subunits of the SDH have been found mutated in association with these different phenotypes, we propose that the wide clinical spectrum actually originates from the specific roles of the SDH in the respirat… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

4
155
1
3

Year Published

2004
2004
2023
2023

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 220 publications
(168 citation statements)
references
References 20 publications
4
155
1
3
Order By: Relevance
“…The positive correlation between the increase in oxidative modification and the decrease in coupled and overall complex activity suggests that this modification affects either the substrate binding or the electron transfer ability of SDHA, or both. This is consistent with the observation that deficiency in and mutation of SDH subunits are known to cause severe diseases in humans and may thus support the argument that modifications in SDHA can lead to structural and functional changes similar to those caused by genetic mutations [34,35]. Thus, we show for the first time that the increase of in vivo oxidative modification of SDHA subunit directly correlates to an age-associated functional deficiency in CII.…”
Section: Discussionsupporting
confidence: 77%
“…The positive correlation between the increase in oxidative modification and the decrease in coupled and overall complex activity suggests that this modification affects either the substrate binding or the electron transfer ability of SDHA, or both. This is consistent with the observation that deficiency in and mutation of SDH subunits are known to cause severe diseases in humans and may thus support the argument that modifications in SDHA can lead to structural and functional changes similar to those caused by genetic mutations [34,35]. Thus, we show for the first time that the increase of in vivo oxidative modification of SDHA subunit directly correlates to an age-associated functional deficiency in CII.…”
Section: Discussionsupporting
confidence: 77%
“…Due to its unique redox properties, and in partnership with ubiquinone, SDH activity maintains a high reduction state of the ubiquinone pool which in turns improves the anti-oxidant capacity of mitochondria, and thus the resistance to oxidative stress [43]. Although we did not find any change in the activity of isolated complex II following treatment with CORM-3, further work should be undertaken to verify whether a direct effect of CO on this complex uncouples mitochondria in respiring cells.…”
Section: Discussioncontrasting
confidence: 43%
“…Additionally, recent studies showed that complex II was an additional site of ROS generation (McLennan and Degli Esposti, 2000). Succinate dehyrogenase (SDH), which forms a part of complex II, catalyses the oxidation of succinate to fumarate in the Krebs cycle, and feeds electrons to the respiratory chain ubiquinone pool (Rustin et al, 2002). Previously, we showed that MeHg treatment increased O 2 -generation in the cerebellum mitochondria when succinate was used as a substrate (Mori et al, 2007).…”
Section: Resultsmentioning
confidence: 99%